Laconic 发表于 2025-3-23 11:42:59

http://reply.papertrans.cn/3/224/22302/22302-11.png

condescend 发表于 2025-3-23 14:49:48

http://reply.papertrans.cn/3/224/22302/22302-12.png

GUILT 发表于 2025-3-23 19:14:59

http://reply.papertrans.cn/3/224/22302/22302-13.png

overweight 发表于 2025-3-24 00:09:38

Submitted on: 31 May 2009.
Revised on: 12 July 2009.
Accepted on: 23 July 2009.
MOLECULAR THERAPY---CELL PRESS

轮流 发表于 2025-3-24 04:53:47

http://reply.papertrans.cn/3/224/22302/22302-15.png

没有希望 发表于 2025-3-24 07:38:35

Submitted on: 09 December 2017.
Revised on: 14 January 2018.
Accepted on: 09 February 2018.
MOLECULAR THERAPY---CELL PRESS

考得 发表于 2025-3-24 10:42:54

Submitted on: 19 May 2023.
Revised on: 22 June 2023.
Accepted on: 12 July 2023.
MOLECULAR THERAPY

Control-Group 发表于 2025-3-24 16:46:09

Submitted on: 07 April 2002.
Revised on: 10 May 2002.
Accepted on: 06 June 2002.
MOLECULAR THERAPY

的阐明 发表于 2025-3-24 21:30:47

Submitted on: 07 July 2007.
Revised on: 18 August 2007.
Accepted on: 04 September 2007.
MOLECULAR THERAPY---CELL PRESS

entreat 发表于 2025-3-25 02:07:01

Submitted on: 14 March 2003.
Revised on: 23 April 2003.
Accepted on: 29 April 2003.
MOLECULAR THERAPY
页: 1 [2] 3 4
查看完整版本: SCIE期刊MOLECULAR THERAPY 2024/2025影响因子:12.176 (MOL THER) (1525-0016). (BIOTECHNOLOGY & APPLIED MICROBIOLOGY)(生物技术与应用微生物学